Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Unilever

Article Abstract:

Unilever is investing in its main 400 brands to boost top-line growth by 5%. The company has seen a need to tackle the problem of revenue growth so that it becomes more attractive to investors. There will be cost savings from 2001, though earnings are not likely to be enhanced prior to 2003. Credit Suisse First Boston rates the company's stocks a hold, while Lehman Brothers rates them 'outperform', seeing better value elsehwere. JP Morgan's verdict is 'market perform' with the valuation a reflection of the uncertainties of the new strategy.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2000

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Unilever

Article Abstract:

Unilever has acquired Ben and Jerry's and Slimfast, moves that Investec Henderson Croswaithe sees as helping to raise margins, rating Unilever's stocks a buy. Ing Barings also rates the stocks a buy, while JP Morgan gives a marketperform rating.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2000

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Unilever

Article Abstract:

Unilever suffers from poor sales growth and has a major restructuring task, but appears to have made a good acquisition in BestFoods.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2000

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Management, Food industry, Unilever Group
Similar abstracts:
  • Abstracts: Stanley Leisure. ENIC. One to bet on
  • Abstracts: Viglen. IBM. Dicom
  • Abstracts: Hilton
  • Abstracts: Making a mint from technofear. Rerating overdue. CMG
  • Abstracts: Oxford Glycosciences. Powderject Pharma
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.